First Time Loading...

EyePoint Pharmaceuticals Inc
NASDAQ:EYPT

Watchlist Manager
EyePoint Pharmaceuticals Inc Logo
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Watchlist
Price: 16.75 USD 3.65% Market Closed
Updated: Apr 28, 2024

EyePoint Pharmaceuticals Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

EyePoint Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Cash from Investing Activities
-$3.3m
CAGR 3-Years
-110%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Investing Activities
$878m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Investing Activities
-$2.3B
CAGR 3-Years
40%
CAGR 5-Years
-21%
CAGR 10-Years
-15%
Pfizer Inc
NYSE:PFE
Cash from Investing Activities
-$32.3B
CAGR 3-Years
-96%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Merck & Co Inc
NYSE:MRK
Cash from Investing Activities
-$14.1B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
-16%
Eli Lilly and Co
NYSE:LLY
Cash from Investing Activities
-$7.2B
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
-13%

See Also

What is EyePoint Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
-3.3m USD

Based on the financial report for Dec 31, 2023, EyePoint Pharmaceuticals Inc's Cash from Investing Activities amounts to -3.3m USD.

What is EyePoint Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
28%

Over the last year, the Cash from Investing Activities growth was 81%. The average annual Cash from Investing Activities growth rates for EyePoint Pharmaceuticals Inc have been -110% over the past three years , 28% over the past five years .